Kirsten rat sarcoma oncogene test market
Disease awareness boosts Japan’s KRAS oncogene test market
Disease awareness boosts Japan’s KRAS oncogene test market
Nucleic acid amplification tests dominate the market.
Join the community
Most Read
1. US tariffs trigger 123% Singapore pharma output surge 2. Australia commits $80.33m to 60 medical research projects 3. Shape the future of sustainable medicine with NUS’ programmes 4. Tam Anh group launches $95m university in Vietnam 5. Australia commits $80.33m to 60 medical research trialsResource Center
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.